Grants and Contributions:
Title:
Rapid Detection of Pathogens using Nanoparticles
Agreement Number:
946629
Agreement Value:
$82,800.00
Agreement Date:
Jan 1, 2020 - Mar 31, 2021
Description:
Genemis Laboratories intends to expand detection capabilities of its proprietary rapid detection technology, by developing microorganism-specific reagents.
Organization:
National Research Council Canada
Expected Results:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Location:
Cambridge, Ontario, CA N1R 8B5
Reference Number:
172-2019-2020-Q4-946629
Agreement Type:
Contribution
Report Type:
Grants and Contributions
Recipient Business Number:
840169734
Recipient Type:
For-profit organization
Additional Information:
This agreement has been amended 1 time(s). The end date of this agreements has been modified by 90 days.
Amendment Date
Dec 21, 2020
Recipient's Legal Name:
Genemis Laboratories Inc.
Federal Riding Name:
Cambridge
Federal Riding Number:
35016
Program:
Industrial Research Assistance Program – Contributions to Firms
Program Purpose:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Coverage:
IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation.
NAICS Code:
221310
Amendments: